Diagnosis and treatment of iron deficiency anemia during pregnancy and the postpartum period: Iron deficiency anemia working group consensus report
- PMID: 28913064
- PMCID: PMC5558393
- DOI: 10.4274/tjod.01700
Diagnosis and treatment of iron deficiency anemia during pregnancy and the postpartum period: Iron deficiency anemia working group consensus report
Abstract
According to the World Health Organization (WHO), anemia is the most common disease, affecting >1.5 billion people worldwide. Furthermore, iron deficiency anemia (IDA) accounts for 50% of cases of anemia. IDA is common during pregnancy and the postpartum period, and can lead to serious maternal and fetal complications. The aim of this report was to present the experiences of a multidisciplinary expert group, and to establish reference guidelines for the optimal diagnosis and treatment of IDA during pregnancy and the postpartum period. Studies and guidelines on the diagnosis and treatment of IDA published in Turkish and international journals were reviewed. Conclusive recommendations were made by an expert panel aiming for a scientific consensus. Measurement of serum ferritin has the highest sensitivity and specificity for diagnosis of IDA unless there is a concurrent inflammatory condition. The lower threshold value for hemoglobin (Hb) in pregnant women is <11 g/dL during the 1st and 3rd trimesters, and <10.5 g/dL during the 2nd trimester. In postpartum period a Hb concentration <10 g/dL indicates clinically significant anemia. Oral iron therapy is given as the first-line treatment for IDA. Although current data are limited, intravenous (IV) iron therapy is an alternative therapeutic option in patients who do not respond to oral iron therapy, have adverse reactions, do not comply with oral iron treatment, have a very low Hb concentration, and require rapid iron repletion. IV iron preparations can be safely used for the treatment of IDA during pregnancy and the postpartum period, and are more beneficial than oral iron preparations in specific indications.
Keywords: Iron deficiency anemia; Pregnancy; intravenous iron therapy; postpartum period.
Conflict of interest statement
Conflict of Interest: C Breymann is a medical advisor of Vifor International/Switzerland in the field of iron deficiency in Obstetrics and Gynecology. O Api, M Çetiner, C Demir, T Ecder, and F Yavuz declare that there are no conflicts of interest.
Figures
References
-
- Worldwide prevalence of anaemia. 1993-2005. 2008. [Internet] http://whqlibdoc.who.int/publications/2008/ 9789241596657_eng.pdf .
-
- WHO meeting report. Preconception care to reduce maternal and childhood mortality & morbidity. 2012. [Internet] http://apps.who.int/iris/bitstream/10665/78067/1/9789241505000_eng.pdf .
-
- Beştepe G, Bilgin N. Afyon ili 2 ve 4 no’lu sağlık ocaklarındaki gebelerde anemi prevalansı ve anemiyi etkileyen bazı faktörlerin incelenmesi. Sağlık ve Toplum. 2002;12:45–53.
-
- Mersin S, Kuş C, Yeşildal N, Mayda AS, Şerifi B. Konuralp Kamil Furtun Sağlık Ocağı bölgesi gebelerde anemi araştırması. Diyarbakır: 8. Ulusal Halk Sağlığı Kongresi Bildiri Kitabı; 2002. pp. 257–60.
-
- Oruç O, Tuncer A, Apan E. Adana Yenibaraj Sağlık Ocağı bölgesinde gebelerde anemi prevalansı. İstanbul: 5. Ulusal Halk Sağlığı Kongresi Bildiri Kitabı; 1996. pp. 374–8.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous